JNJ vs MRK: Dividend Comparison

At $243.53 per share, $10,000 buys about 41.1 shares of Johnson & Johnson (JNJ). Each share pays $5.14 per year in dividends, so the position starts out generating roughly $211 per year — about $18 a month.

At $121.49 per share, $10,000 buys about 82.3 shares of Merck & Co., Inc. (MRK). Each share pays $3.24 per year in dividends, so the position starts out generating roughly $267 per year — about $22 a month.

MRK is the larger income stream from day one: $56 per year more on the same $10,000 invested.

Johnson & Johnson (JNJ) has raised its dividend about 5.2% a year over the past five years. If that pace held, the $216 per year that $10,000 generates today at the current 2.16% yield would reach $359 per year by 2036 — a 3.6% yield on the original cost.

Merck & Co., Inc. (MRK) has raised its dividend about 5.9% a year over the past five years. If that pace held, the $277 per year that $10,000 generates today at the current 2.77% yield would reach $490 per year by 2036 — a 4.9% yield on the original cost.

On those trailing rates, MRK pays more in 2036: $490 versus $359 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

It doesn't, on the trailing numbers. Merck & Co., Inc. (MRK) yields more today (2.77% vs 2.16%) and has also grown its dividend at least as fast (5.9% vs 5.2% a year over five years). Unless JNJ accelerates its raises or MRK stumbles, JNJ never closes the income gap — MRK wins on both current income and growth.

Johnson & Johnson (JNJ) earns $11.03 per share against $5.14 paid out in dividends — 2.1x coverage (a 47% payout ratio).

Merck & Co., Inc. (MRK) earns $7.28 per share against $3.24 paid out in dividends — 2.2x coverage (a 45% payout ratio).

Coverage is similar for both, so neither dividend looks meaningfully more stretched than the other on current earnings.

For income you need right now, Merck & Co., Inc. (MRK) leads: $100,000 invested today pays about $230 a month at the current 2.77% yield, versus $180 a month from Johnson & Johnson (JNJ) at 2.16%.

MRK also leads on dividend growth (5.9% vs 5.2% a year over five years), so the trailing numbers favor it on both fronts.

On consistency: JNJ has raised its dividend 63 consecutive years; MRK has raised its dividend 15 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.